What other stocks do shareholders of ProMetic Life Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ProMetic Life Sciences investors own include Nemaska Lithium (NMX) , ProMetic Life Sciences (PFSCF) , Bombardier, Inc. Class B (BBD.B) , Crescent Point Energy (CPG) , Sierra Wireless (SWIR) , Baytex Energy (BTE) , Dollarama (DOL) , Parkland (PKI) , Aurora Cannabis (ACB) and Resverlogix (RVX) .

How do I buy shares of ProMetic Life Sciences?

Shares of PLI stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor , Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. Compare Top Brokerages Here .

TSE:PLI

ProMetic Life Sciences (PLI) Stock Price, News & Analysis

→ Forget NVIDIA, buy this $2 AI stock now… (From Behind the Markets) (Ad)

Free PLI Stock Alerts

Compare

Today's Range: N/A
50-Day Range: C$13.60
▼
C$13.60
52-Week Range: N/A

Volume: 921 shs
Average Volume: 8,002 shs
Market Capitalization: C$317.06 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get ProMetic Life Sciences alerts:

Ad Behind the Markets

Will this $2 AI stock double overnight?

It's a tiny AI company fighting for a big piece of a $20 Billion Pentagon contract. What's more, this groundbreaking firm is trading for less than $2 a share!

Click here to learn more >>>

About ProMetic Life Sciences Stock (TSE:PLI)

Prometic Life Sciences Inc. operates as a biopharmaceutical company with two drug discovery platforms that focuses on unmet medical needs in the field of fibrosis and orphan diseases. Its product pipeline includes PBI-4050, an orally active lead drug candidate for fibrosis; plasminogen, a biopharmaceutical for the treatment of congenital plasminogen deficiency; and intravenous immunoglobulin, a preparation of antibodies purified from plasma donations from healthy individuals. The company was founded in 1992 and is based in Laval, Canada.

Ad Behind the Markets

Will this $2 AI stock double overnight?

It's a tiny AI company fighting for a big piece of a $20 Billion Pentagon contract. What's more, this groundbreaking firm is trading for less than $2 a share!

Click here to learn more >>>

PLI Stock News Headlines

July 24, 2023 | investing.com

TMC Life Sciences Bhd (TMCN)

February 21, 2023 | finance.yahoo.com

Arithmos appoints Maurizio Giraudo as Managing Director of the new Life Sciences Business Consulting Unit

April 19, 2024 | Behind the Markets (Ad)

Forget NVIDIA, buy this $2 AI stock now…

This company is at the center of a trillion-dollar industry, fighting for a piece of a massive $20 billion pentagon contract.

July 31, 2021 | fool.ca

TSX:CVE (CENOVUS ENERGY INC.)

See More Headlines

Receive PLI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ProMetic Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: TSE
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: TSE:PLI
CUSIP: N/A
CIK: N/A
Web: prometic.com
Phone: +1-450-7810115
Fax: N/A
Employees: 487
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: 37.47
Current Ratio: 4.06
Quick Ratio: 3.66

Sales & Book Value

Annual Sales: C$39.91 million
Price / Sales: 0.00
Cash Flow: N/A
Price / Cash Flow: 3.94
Book Value: C$6.07 per share
Price / Book: N/A

Miscellaneous

Outstanding Shares: 23,313,000
Free Float: N/A
Market Cap: C$317.06 million
Optionable: Not Optionable
Beta: N/A

10 "Recession Proof" Stocks That Will Thrive in Any Market

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

Mr. Kenneth H. Galbraith (Age 56)
CEO & Director
Mr. Bruce Pritchard
International COO & Interim CFO
Mr. Patrick Sartore
Chief Legal Officer & Corp. Sec.
Mr. Bruce Wendel (Age 65)
Chief Bus. Devel. Officer
Dr. John Moran (Age 73)
Chief Medical Officer

Key Competitors

View All Competitors

PLI Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of ProMetic Life Sciences own?: Based on aggregate information from My MarketBeat watchlists, some companies that other ProMetic Life Sciences investors own include Nemaska Lithium (NMX), ProMetic Life Sciences (PFSCF), Bombardier, Inc. Class B (BBD.B), Crescent Point Energy (CPG), Sierra Wireless (SWIR), Baytex Energy (BTE), Dollarama (DOL), Parkland (PKI), Aurora Cannabis (ACB) and Resverlogix (RVX).
How do I buy shares of ProMetic Life Sciences?: Shares of PLI stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (TSE:PLI) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

ProMetic Life Sciences (PLI) Stock Price, News & Analysis

About ProMetic Life Sciences Stock (TSE:PLI)

PLI Stock News Headlines

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

PLI Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info